ASND

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Ascendis Pharma AS

NASDAQ | ASND

212.33

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 28, 2025)

$12.83B

Market Cap

-

P/E Ratio

-4.41

EPS

$223.19

52 Week High

$118.03

52 Week Low

HEALTHCARE

Sector

ASND Chart

Recent Chart
Price Action

ASND Technicals

Tags:

ASND Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (EUR)
Gross Profit $319M
Total Revenue $364M
Cost Of Revenue $44M
Costof Goods And Services Sold $44M
Operating Income -$279M
Selling General And Administrative $285M
Research And Development $307M
Operating Expenses $598M
Investment Income Net -
Net Interest Income -$51M
Interest Income $14M
Interest Expense $66M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $18M
Income Before Tax -$373M
Income Tax Expense $4.8M
Interest And Debt Expense -
Net Income From Continuing Operations -$378M
Comprehensive Income Net Of Tax -
Ebit -$308M
Ebitda -$290M
Net Income -$378M

Revenue & Profitability

Earnings Performance

ASND Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (EUR)
Total Assets $1.2B
Total Current Assets $1.1B
Cash And Cash Equivalents At Carrying Value $560M
Cash And Short Term Investments $560M
Inventory $296M
Current Net Receivables $166M
Total Non Current Assets $119M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $533K
Intangible Assets Excluding Goodwill $533K
Goodwill $3.5M
Investments -
Long Term Investments $14M
Short Term Investments $0
Other Current Assets $39M
Other Non Current Assets -
Total Liabilities $1.3B
Total Current Liabilities $908M
Current Accounts Payable $96M
Deferred Revenue -
Current Debt -
Short Term Debt $492M
Total Non Current Liabilities $377M
Capital Lease Obligations -
Long Term Debt $365M
Current Long Term Debt $492M
Long Term Debt Noncurrent -
Short Long Term Debt Total $857M
Other Current Liabilities $318M
Other Non Current Liabilities -
Total Shareholder Equity -$106M
Treasury Stock -
Retained Earnings -$2.6B
Common Stock $8.1M
Common Stock Shares Outstanding $58M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (EUR)
Operating Cashflow -$306M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $18M
Capital Expenditures $1.4M
Change In Receivables -
Change In Inventory -$87M
Profit Loss -
Cashflow From Investment $6.9M
Cashflow From Financing $444M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity $0
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$378M

yearly Income Statement (As of Dec 31, 2024)

Field Value (EUR)
Gross Profit $319M
Total Revenue $364M
Cost Of Revenue $44M
Costof Goods And Services Sold $44M
Operating Income -$279M
Selling General And Administrative $285M
Research And Development $307M
Operating Expenses $598M
Investment Income Net -
Net Interest Income -$51M
Interest Income $14M
Interest Expense $66M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $18M
Income Before Tax -$373M
Income Tax Expense $4.8M
Interest And Debt Expense -
Net Income From Continuing Operations -$378M
Comprehensive Income Net Of Tax -
Ebit -$308M
Ebitda -$290M
Net Income -$378M

ASND News

ASND Profile

Ascendis Pharma AS Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Ascendis Pharma A/S is a biopharmaceutical innovator based in Hellerup, Denmark, dedicated to creating transformative therapies for significant unmet medical needs in various therapeutic areas, particularly rare diseases and endocrine disorders. Leveraging its proprietary TransConâ„¢ technology platform, the company is actively advancing a promising pipeline of product candidates through rigorous clinical trials. Ascendis is focused not only on developing groundbreaking treatments but also on establishing a sustainable business model that prioritizes patient health and supports long-term growth initiatives.

LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
KTTA
+38.67%
$1.47
NVDA
-1.80%
$177.00
VINE
+10.76%
$0.39
HBI
-1.82%
$6.47
AMZE
+19.82%
$0.47
TLRY
-21.06%
$0.81
INTC
+10.18%
$40.56
BITF
+12.25%
$3.48
IPG
-1.95%
$24.57
TWOH
-15.38%
$0.00
YGMZ
-9.59%
$0.11
BYND
-3.74%
$0.98
AXDX
-61.36%
$0.03
RUBI
-26.17%
$0.15
BMNR
+4.34%
$33.12
CLSK
+12.26%
$15.10
ADAP
-15.14%
$0.05
ASST
-0.88%
$1.12
HOOD
+10.92%
$128.20
PLUG
+1.51%
$2.01
SOND
-23.45%
$0.12
SNAP
+0.72%
$7.66
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
CHR
-4.86%
$0.04
INHD
-0.97%
$0.22
ADD
-25.47%
$0.05
AAL
+0.86%
$14.05
BIYA
+17.05%
$0.29
TSLA
+0.84%
$430.17
SRM
+53.27%
$10.30
CIFR
+6.26%
$20.35
ONMD
+30.28%
$1.85
BMNU
+8.77%
$8.18
ONDS
-4.12%
$7.90
MARA
+6.30%
$11.81
WULF
+4.51%
$15.51
NIO
+0.82%
$5.50
F
+0.45%
$13.25
BURU
+10.43%
$0.24
WLGS
-5.57%
$0.04
GPUS
-9.24%
$0.30
NFLX
+1.66%
$106.14
MTSR
-0.35%
$70.50
SOFI
+4.31%
$29.72
VALE
+0.79%
$12.61
GOOGL
+0.07%
$320.18
BTBT
+2.58%
$2.38
DEFT
+9.35%
$1.52
ADTX
+21.01%
$3.80
BTG
+3.80%
$4.64
ACHR
+4.40%
$7.82
GRAB
+2.44%
$5.45
AFMD
-34.94%
$0.18
DVLT
-4.69%
$2.03
PFE
0.00%
$25.71
CAN
+0.75%
$0.92
CRCL
+10.02%
$79.92
SMX
+250.80%
$61.04
KWM
+13.63%
$0.75
DNN
-0.19%
$2.55
BABA
+0.37%
$157.60
IBRX
+10.79%
$2.36
VEEE
+45.50%
$2.59
RIOT
+7.82%
$16.13
AMZN
+1.77%
$233.22
AAPL
+0.46%
$278.85
AIIO
-9.09%
$0.70
MSTR
+2.00%
$175.64
WBD
+0.50%
$24.00
AG
+12.65%
$15.22
APLD
+8.66%
$27.10
NGD
+6.76%
$8.37
GOOG
-0.05%
$320.12
IREN
-1.32%
$47.81
RIG
+2.09%
$4.39
GRYP
-10.38%
$1.38
BAC
+1.28%
$53.67
MODV
-25.22%
$0.43
AMD
+1.53%
$217.53
RIVN
+4.20%
$16.86
SMR
+5.04%
$20.00
WMT
+1.96%
$109.10
TMC
+19.38%
$6.96
PLTR
+1.61%
$168.45
CDE
+6.76%
$17.28
ITUB
+1.82%
$7.80
AGNC
-0.66%
$10.49
CRCA
+19.56%
$4.40
KDLY
+7.20%
$0.49
T
+0.77%
$26.02
AMC
+6.30%
$2.44
NVO
+1.21%
$49.30
CRCG
+20.00%
$2.82
META
-0.41%
$633.61
SAND
-6.04%
$12.12
BBD
+0.67%
$3.70
BTE
+2.05%
$3.22
LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
KTTA
+38.67%
$1.47
NVDA
-1.80%
$177.00
VINE
+10.76%
$0.39
HBI
-1.82%
$6.47
AMZE
+19.82%
$0.47
TLRY
-21.06%
$0.81
INTC
+10.18%
$40.56
BITF
+12.25%
$3.48
IPG
-1.95%
$24.57
TWOH
-15.38%
$0.00
YGMZ
-9.59%
$0.11
BYND
-3.74%
$0.98
AXDX
-61.36%
$0.03
RUBI
-26.17%
$0.15
BMNR
+4.34%
$33.12
CLSK
+12.26%
$15.10
ADAP
-15.14%
$0.05
ASST
-0.88%
$1.12
HOOD
+10.92%
$128.20
PLUG
+1.51%
$2.01
SOND
-23.45%
$0.12
SNAP
+0.72%
$7.66
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
CHR
-4.86%
$0.04
INHD
-0.97%
$0.22
ADD
-25.47%
$0.05
AAL
+0.86%
$14.05
BIYA
+17.05%
$0.29
TSLA
+0.84%
$430.17
SRM
+53.27%
$10.30
CIFR
+6.26%
$20.35
ONMD
+30.28%
$1.85
BMNU
+8.77%
$8.18
ONDS
-4.12%
$7.90
MARA
+6.30%
$11.81
WULF
+4.51%
$15.51
NIO
+0.82%
$5.50
F
+0.45%
$13.25
BURU
+10.43%
$0.24
WLGS
-5.57%
$0.04
GPUS
-9.24%
$0.30
NFLX
+1.66%
$106.14
MTSR
-0.35%
$70.50
SOFI
+4.31%
$29.72
VALE
+0.79%
$12.61
GOOGL
+0.07%
$320.18
BTBT
+2.58%
$2.38
DEFT
+9.35%
$1.52
ADTX
+21.01%
$3.80
BTG
+3.80%
$4.64
ACHR
+4.40%
$7.82
GRAB
+2.44%
$5.45
AFMD
-34.94%
$0.18
DVLT
-4.69%
$2.03
PFE
0.00%
$25.71
CAN
+0.75%
$0.92
CRCL
+10.02%
$79.92
SMX
+250.80%
$61.04
KWM
+13.63%
$0.75
DNN
-0.19%
$2.55
BABA
+0.37%
$157.60
IBRX
+10.79%
$2.36
VEEE
+45.50%
$2.59
RIOT
+7.82%
$16.13
AMZN
+1.77%
$233.22
AAPL
+0.46%
$278.85
AIIO
-9.09%
$0.70
MSTR
+2.00%
$175.64
WBD
+0.50%
$24.00
AG
+12.65%
$15.22
APLD
+8.66%
$27.10
NGD
+6.76%
$8.37
GOOG
-0.05%
$320.12
IREN
-1.32%
$47.81
RIG
+2.09%
$4.39
GRYP
-10.38%
$1.38
BAC
+1.28%
$53.67
MODV
-25.22%
$0.43
AMD
+1.53%
$217.53
RIVN
+4.20%
$16.86
SMR
+5.04%
$20.00
WMT
+1.96%
$109.10
TMC
+19.38%
$6.96
PLTR
+1.61%
$168.45
CDE
+6.76%
$17.28
ITUB
+1.82%
$7.80
AGNC
-0.66%
$10.49
CRCA
+19.56%
$4.40
KDLY
+7.20%
$0.49
T
+0.77%
$26.02
AMC
+6.30%
$2.44
NVO
+1.21%
$49.30
CRCG
+20.00%
$2.82
META
-0.41%
$633.61
SAND
-6.04%
$12.12
BBD
+0.67%
$3.70
BTE
+2.05%
$3.22
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.